ClinicalTrials.gov
ClinicalTrials.gov Menu

Riboflavin Mediated Corneal Crosslinking for Stabilizing Progression of Keratoconus (CCL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00626717
Recruitment Status : Completed
First Posted : February 29, 2008
Last Update Posted : January 17, 2013
Sponsor:
Collaborator:
Peschke Meditrade, GmbH
Information provided by (Responsible Party):
D Dr. Philip Maier, University Hospital Freiburg

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2012
  Actual Study Completion Date : December 2012